Andrew Cowan

Title: Andrew Cowan - Innovator in Arginine-Rich Polypeptide Compositions

Introduction

Andrew Cowan is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of biochemistry, particularly in the development of polypeptide compositions that have potential therapeutic applications.

Latest Patents

Cowan holds a patent for "Arginine-rich polypeptide compositions and methods of using same." This innovative composition includes an arginine-rich polypeptide and a pharmaceutically acceptable carrier. The polypeptide consists of at least nine arginine residues, which represent at least 10% of the amino acid residues in the polypeptide. This composition can be utilized in methods to inhibit the human papilloma virus (HPV) from binding to cells, as well as in treating subjects who have or are at risk of HPV infections. He has 1 patent to his name.

Career Highlights

Cowan is affiliated with the University of New Mexico, where he conducts research and develops his innovative ideas. His work focuses on the intersection of biochemistry and medicine, aiming to create solutions that can improve health outcomes.

Collaborations

Some of his notable coworkers include Michelle A Ozbun and Zurab Surviladze. Their collaborative efforts contribute to advancing research in the field of virology and therapeutic applications.

Conclusion

Andrew Cowan's work in arginine-rich polypeptide compositions showcases his commitment to innovation in biochemistry. His contributions have the potential to impact the treatment of viral infections significantly.